327 related articles for article (PubMed ID: 36477831)
1. Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom.
Hiroyasu S; Barit JJG; Hiroyasu A; Tsuruta D
J Dermatol; 2023 Feb; 50(2):150-161. PubMed ID: 36477831
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
Gardner KM; Crawford RI
J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
[TBL] [Abstract][Full Text] [Related]
3. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.
Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM
An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405
[TBL] [Abstract][Full Text] [Related]
4. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
5. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid.
Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T
Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Pruritus in Bullous Pemphigoid and Impact on Quality of Life: A Prospective Cohort Study.
Briand C; Gourier G; Poizeau F; Jelti L; Bachelerie M; Quéreux G; Jeudy G; Acquitter M; Ingen-Housz-Oro S; Caux F; Prost C; Darrigade AS; Heron Mermin D; Mahé E; Picart Dahan C; Richard MA; Clerc CJ; Salle De Chou C; Plée J; Abasq-Thomas C; Misery L; Brenaut E
Acta Derm Venereol; 2020 Nov; 100(18):adv00320. PubMed ID: 33135772
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study.
Hu L; Huang R; Jiang F; You S; Wu Q
Immun Inflamm Dis; 2023 Jul; 11(7):e924. PubMed ID: 37506153
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.
Duschet P; Gschnait F
Clin Exp Dermatol; 1991 Sep; 16(5):403-4. PubMed ID: 1794202
[No Abstract] [Full Text] [Related]
10. Bullous autoimmune dermatoses.
Hofmann SC; Juratli HA; Eming R
J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
[TBL] [Abstract][Full Text] [Related]
12. Vesiculobullous Lesions of the Oral Cavity.
Alramadhan SA; Islam MN
Oral Maxillofac Surg Clin North Am; 2023 May; 35(2):203-217. PubMed ID: 37019505
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiologic mechanisms of itch in bullous pemphigoid.
Hashimoto T; Kursewicz CD; Fayne RA; Nanda S; Shah SM; Nattkemper L; Yokozeki H; Yosipovitch G
J Am Acad Dermatol; 2020 Jul; 83(1):53-62. PubMed ID: 31351883
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in the pathogenesis of pruritus in bullous pemphigoid.
Sun C; Feng S
Int J Dermatol; 2021 Dec; 60(12):1441-1448. PubMed ID: 34037252
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients.
Miller AC; Temiz LA; Adjei S; Duran MA; Sassmannshausen J; Dominguez A; Thomas C; Schmidt JD; Bernhardt M; Doolittle-Amieva CJ; Moshiri AS; Thompson AJ; Pyoung Kim-Lim P; Mattia AV; Tyring SK
J Drugs Dermatol; 2024 Jun; 23(6):e144-e148. PubMed ID: 38834228
[TBL] [Abstract][Full Text] [Related]
16. A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita.
Patel PM; Jones VA; Murray TN; Amber KT
Am J Clin Dermatol; 2020 Aug; 21(4):557-565. PubMed ID: 32180161
[TBL] [Abstract][Full Text] [Related]
17. Bullous pemphigoid as pruritus in the elderly: a common presentation.
Bakker CV; Terra JB; Pas HH; Jonkman MF
JAMA Dermatol; 2013 Aug; 149(8):950-3. PubMed ID: 23804286
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid.
Ben Mordehai Y; Faibish H; Astman N; Greenberger S; Barzilai A; Baum S
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):161-165. PubMed ID: 31423677
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune blistering diseases in the elderly.
Parker SR; MacKelfresh J
Clin Dermatol; 2011; 29(1):69-79. PubMed ID: 21146735
[TBL] [Abstract][Full Text] [Related]
20. [Pemphigoid mimicking epidermolysis bullosa acquisita].
Delaporte E; Piette F; Janin A; Cozzani E; Joly P; Thomine E; Nicolas JF; Bergoend H
Ann Dermatol Venereol; 1995; 122(1-2):19-22. PubMed ID: 7668776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
